Company
Urania Therapeutics
Developing treatments for genetic diseases and cancers caused by nonsense mutations.
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
- Founded
- 2015
Claim, correct or request removal
Record updated 28 September 2026
About
Urania is developing readthrough compounds targeting the human ribosome following a structure-based drug design approach for the treatment of genetic diseases and some cancers caused by nonsense mutations.
Funding snapshot
- Latest round
- Grant2020-01-14
Funding rounds
- Grant
- 2020-01-14
- Seed
- 2019-11-06
Loading relationship preview